Page last updated: 2024-08-26

imipenem, anhydrous and Bile Duct Obstruction

imipenem, anhydrous has been researched along with Bile Duct Obstruction in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Anjary, A; Bende, F; Burciu, C; Dalati, S; Gadour, E; Horhat, FG; Miuțescu, B; Moga, T; Popescu, A; Rațiu, I; Sabuni, O; Turcu-Stiolica, A; Ungureanu, BS; Vuletici, D1
Chan, CY; Cheng, AF; French, GL; Ko, TC; Lai, CW; Leung, JW1

Other Studies

2 other study(ies) available for imipenem, anhydrous and Bile Duct Obstruction

ArticleYear
Identification of Microbial Species and Analysis of Antimicrobial Resistance Patterns in Acute Cholangitis Patients with Malignant and Benign Biliary Obstructions: A Comparative Study.
    Medicina (Kaunas, Lithuania), 2023, Apr-06, Volume: 59, Issue:4

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Ceftazidime; Cholangitis; Cholestasis; Drug Resistance, Bacterial; Escherichia coli; Humans; Imipenem; Meropenem; Retrospective Studies

2023
Effect of biliary obstruction on the hepatic excretion of imipenem-cilastatin.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Bile; Cholestasis; Cilastatin; Female; Humans; Imipenem; Infusions, Intravenous; Liver; Male; Middle Aged

1992